Good results but bad guidance.

Good results but bad guidance. Still long term should be a duopoly with Eli Lilly

Novo Nordisk Reports Strong 2025 Sales Growth with Mixed Operating Profit Results

Novo Nordisk announced its full-year 2025 financial results, reporting sales of DKK 309.1 billion, a 6% increase in Danish kroner and 10% growth at constant exchange rates. Operating profit showed a mixed performance, declining 1% in local currency but rising 6% at constant exchange rates, impacted by transformation costs. The company highlighted strong demand for obesity treatments and expects competitive pricing pressures and regulatory decisions in 2026. Despite a stock price drop post-report, the results reflect robust volume growth and innovation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":529097142423840,"tweetId":"529097142423840","gmtCreate":1770196149128,"gmtModify":1770196153418,"author":{"id":3586737504816693,"idStr":"3586737504816693","authorId":3586737504816693,"authorIdStr":"3586737504816693","name":"Gohsan","avatar":"https://static.tigerbbs.com/1d6f85e2e2b1853fa8ee2af0924ec302","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":114,"starInvestorFlag":false},"themes":[{"themeId":"064c39c5450449ebb187da86a9042d34","categoryId":"2929bb7468f5415f853fd96fb35d7c3b","name":"Novo Nordisk Reports Strong 2025 Sales Growth with Mixed Operating Profit Results","type":2,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":064c39c5450449ebb187da86a9042d34}&rnconfig={\"headerBarHidden\": true}","description":"Novo Nordisk announced its full-year 2025 financial results, reporting sales of DKK 309.1 billion, a 6% increase in Danish kroner and 10% growth at constant exchange rates. Operating profit showed a mixed performance, declining 1% in local currency but rising 6% at constant exchange rates, impacted by transformation costs. The company highlighted strong demand for obesity treatments and expects competitive pricing pressures and regulatory decisions in 2026. Despite a stock price drop post-report, the results reflect robust volume growth and innovation."}],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>Good results but bad guidance. Still long term should be a duopoly with Eli Lilly</p></body></html>","htmlText":"<html><head></head><body><p>Good results but bad guidance. Still long term should be a duopoly with Eli Lilly</p></body></html>","text":"Good results but bad guidance. Still long term should be a duopoly with Eli Lilly","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/529097142423840","repostId":0,"isVote":1,"tweetType":1,"viewCount":20,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":67,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/529097142423840"}